CliffBio
small molecule

OMEPRAZOLE MAGNESIUM

OMEPRAZOLE MAGNESIUM

Loss of exclusivity—loss of exclusivity
CompanySUN PHARMA INDUSTRIES LTD

Drug detail

Brand nameOMEPRAZOLE MAGNESIUM
Active ingredientOMEPRAZOLE MAGNESIUM
StrengthEQ 20MG BASE
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2018
Marketing statusDISCN

More from SUN PHARMA INDUSTRIES LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

OMEPRAZOLE MAGNESIUM patent cliff — loss of exclusivity — | CliffBio